We are live on ! Find out more
SM

Sabby Management Portfolio holdings

AUM $111M
1-Year Est. Return 74.4%
This Fund
S&P 500
This Quarter Est. Return
-5.44%
1 Year Est. Return
-74.4%
3 Year Est. Return
-95.55%
5 Year Est. Return
-99.44%
10 Year Est. Return
-99.5%
AUM
$1.92B
AUM Growth
-$82.3M
Cap. Flow
+$967K
Cap. Flow %
0.05%
Top 10 Hldgs %
52.67%
Holding
387
New
94
Increased
95
Reduced
80
Closed
99

Sector Composition

Rank Sector Weight
1 Miscellaneous 86.19%
2 Healthcare 13.52%
3 Industrials 0.13%
4 Consumer Staples 0.07%
5 Consumer Discretionary 0.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CLVS
101
CALL
DELISTED
Clovis Oncology, Inc.
CLVS
$2.23M 0.12%
1,626
-236
-13% -$3.45K
ZGNX
102
CALL
DELISTED
Zogenix, Inc.
ZGNX
$2.2M 0.11%
12,072
+7,433
+160% +$72.5K
ABT icon
103
CALL
Abbott
ABT
$177B
$2.18M 0.11%
+555
New +$22.1K
NVAX icon
104
CALL
Novavax
NVAX
$1.52B
$2.18M 0.11%
150
+99
+194% +$11.3K
SAGE
105
DELISTED
Sage Therapeutics
SAGE
$2.08M 0.11%
68,950
-31,050
-31% -$1.04M
AMRN
106
CALL
Amarin Corp
AMRN
$292M
$2.03M 0.11%
471
+37
+9% +$1.39K
ARCT icon
107
CALL
Arcturus Therapeutics
ARCT
$432M
$2.01M 0.1%
638
+451
+241% +$14.2K
IMNN icon
108
Imunon
IMNN
$8.08M
$1.93M 0.1%
555
+548
+7,829% +$2.16M
PALI icon
109
Palisade Bio
PALI
$349M
$1.89M 0.1%
+6
New +$3.18M
MNTA
110
CALL
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$1.88M 0.1%
+1,736
New +$17.9K
FWP
111
DELISTED
Forward Pharma A/S American Depositary Shares
FWP
$1.86M 0.1%
14,591
+3,622
+33% +$489K
BDSI
112
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$1.85M 0.1%
785,799
+229,830
+41% +$634K
CGRN
113
DELISTED
Capstone Green Energy Corporation Common Stock
CGRN
$1.84M 0.1%
+133,690
New +$2.05M
ISEE
114
CALL
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$1.84M 0.1%
+361
New +$17.9K
HALO icon
115
CALL
Halozyme
HALO
$12.1B
$1.81M 0.09%
2,101
+72
+4% +$711
OPK icon
116
Opko Health
OPK
$1.16B
$1.78M 0.09%
190,554
+78,543
+70% +$797K
ADYX
117
DELISTED
Adynxx Inc
ADYX
$1.68M 0.09%
25,000
-7,787
-24% -$465K
RDHL
118
Redhill Biopharma
RDHL
$3.53M
$1.61M 0.08%
148
-9
-6% -$104K
FOMX
119
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$1.61M 0.08%
253,706
-6,694
-3% -$44.4K
ACAD icon
120
PUT
Acadia Pharmaceuticals
ACAD
$4.64B
$1.61M 0.08%
495
-898
-64% -$30.1K
KYNB
121
Kyntra Bio
KYNB
$31.9M
$1.6M 0.08%
3,891
-473
-11% -$217K
GWPH
122
CALL
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$1.57M 0.08%
+172
New +$14.5K
MNTA
123
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$1.57M 0.08%
145,600
-134,625
-48% -$1.39M
VNDA icon
124
CALL
Vanda Pharmaceuticals
VNDA
$302M
$1.55M 0.08%
+1,390
New +$13.5K
ASRT
125
CALL
DELISTED
Assertio
ASRT
$1.55M 0.08%
13
-57
-81% -$62.3K

Similar funds

Sabby Management's Q2 2016 Portfolio in Review

As of Q2 2016, Sabby Management held 387 positions worth $1.92B, down 4.1% from $2B the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Sabby Management's Q2 2016 filing shows 94 new, 95 increased, 80 reduced and 99 closed positions. Its largest new stake was Abbott: 264,700 shares worth $10.4M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $22.6M.

By sector, the portfolio is most concentrated in Miscellaneous at 86% of assets, up from 78% a quarter earlier, followed by Healthcare and Industrials.

  • Sabby Management's largest Q2 2016 buy was Abbott: 264,700 shares worth $10.4M.
  • Sabby Management added most to Regeneron Pharmaceuticals in Q2 2016, an estimated $12.5M increase.
  • Sabby Management's biggest Q2 2016 reduction was Biogen, cutting an estimated $7.14M.
  • Sabby Management fully exited State Street SPDR S&P 500 ETF Trust in Q2 2016, selling an estimated $22.6M.
  • Sabby Management's ten largest holdings make up 53% of its $1.92B portfolio in Q2 2016.
  • Sabby Management opened 94 new positions and closed 99 in Q2 2016.
  • Sabby Management's portfolio value fell 4.1% quarter-over-quarter to $1.92B.

Based on Sabby Management's 13F filing for Q2 2016, filed 15 Aug 2016.